Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Heppner

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|February 7, 2018
Dual oxidase: a novel therapeutic target in allergic diseaseAlbert van der Vliet, Karamatullah Danyal, David E Heppner
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|August 22, 2007
Validation of density functional modeling protocols on experimental bis(mu-oxo)/mu-eta2:eta2-peroxo dicopper equilibriaJohn L Lewin, David E Heppner, Christopher J Cramer
RSC Medicinal Chemistry|September 17, 2025
Introduction to the themed collection on kinasesMeizhong Jin, Hayley Binch, David E Heppner, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|December 14, 2005
Models for dioxygen activation by the CuB site of dopamine beta-monooxygenase and peptidylglycine alpha-hydroxylating monooxygenaseBenjamin F Gherman, David E Heppner, William B Tolman, et al.
Journal of Medicinal Chemistry|February 13, 2026
Small-Molecule Drug Discovery Targeting RNAs: Hope or Hype?Congbao Kang, Hung T Nguyen, David E Heppner, et al.
ACS Medicinal Chemistry Letters|February 13, 2026
Structural Studies of Fourth-Generation EGFR Inhibitors Reveal Insights into Selective T790M and C797S TargetingTahereh Damghani, Shenghan Song, Kaly S Lin, et al.
Dalton Transactions (Cambridge, England : 2003)|October 13, 2006
Can an ancillary ligand lead to a thermodynamically stable end-on 1 : 1 Cu-O2 adduct supported by a beta-diketiminate ligand?David E Heppner, Benjamin F Gherman, William B Tolman, et al.
Archives of Biochemistry and Biophysics|January 28, 2017
The role of sulfenic acids in cellular redox signaling: Reconciling chemical kinetics and molecular detection strategiesDavid E Heppner, Yvonne M W Janssen-Heininger, Albert van der Vliet
Journal of Medicinal Chemistry|April 4, 2020
Structural Basis for EGFR Mutant Inhibition by Trisubstituted Imidazole InhibitorsDavid E Heppner, Marcel Günther, Florian Wittlinger, et al.
Journal of the American Chemical Society|May 8, 2020
Rapid Decay of the Native Intermediate in the Metallooxidase Fet3p Enables Controlled Fe<sup>II</sup> Oxidation for Efficient MetabolismStephen M Jones, David E Heppner, Kenny Vu, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|February 7, 2018
Dual oxidase: a novel therapeutic target in allergic diseaseAlbert van der Vliet, Karamatullah Danyal, David E Heppner
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|August 22, 2007
Validation of density functional modeling protocols on experimental bis(mu-oxo)/mu-eta2:eta2-peroxo dicopper equilibriaJohn L Lewin, David E Heppner, Christopher J Cramer
RSC Medicinal Chemistry|September 17, 2025
Introduction to the themed collection on kinasesMeizhong Jin, Hayley Binch, David E Heppner, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|December 14, 2005
Models for dioxygen activation by the CuB site of dopamine beta-monooxygenase and peptidylglycine alpha-hydroxylating monooxygenaseBenjamin F Gherman, David E Heppner, William B Tolman, et al.
Journal of Medicinal Chemistry|February 13, 2026
Small-Molecule Drug Discovery Targeting RNAs: Hope or Hype?Congbao Kang, Hung T Nguyen, David E Heppner, et al.
ACS Medicinal Chemistry Letters|February 13, 2026
Structural Studies of Fourth-Generation EGFR Inhibitors Reveal Insights into Selective T790M and C797S TargetingTahereh Damghani, Shenghan Song, Kaly S Lin, et al.
Dalton Transactions (Cambridge, England : 2003)|October 13, 2006
Can an ancillary ligand lead to a thermodynamically stable end-on 1 : 1 Cu-O2 adduct supported by a beta-diketiminate ligand?David E Heppner, Benjamin F Gherman, William B Tolman, et al.
Archives of Biochemistry and Biophysics|January 28, 2017
The role of sulfenic acids in cellular redox signaling: Reconciling chemical kinetics and molecular detection strategiesDavid E Heppner, Yvonne M W Janssen-Heininger, Albert van der Vliet
Journal of Medicinal Chemistry|April 4, 2020
Structural Basis for EGFR Mutant Inhibition by Trisubstituted Imidazole InhibitorsDavid E Heppner, Marcel Günther, Florian Wittlinger, et al.
Journal of the American Chemical Society|May 8, 2020
Rapid Decay of the Native Intermediate in the Metallooxidase Fet3p Enables Controlled Fe<sup>II</sup> Oxidation for Efficient MetabolismStephen M Jones, David E Heppner, Kenny Vu, et al.
Pageof 6